TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Large Study Finds No Survival Benefit Associated With Removal Of Ovaries January 30, 2009
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
TCL Archive National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg June 28, 1974
